| 1 |
COVID-19-another influential event impacts on laboratory medicine management |
|
| | YunTao Luo,JingHua Wang,MinMin Zhang,QingZhong Wang,Rong Chen,XueLiang Wang,HuaLiang Wang | | | Journal of Clinical Laboratory Analysis. 2021; | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Analytical performance assessment and improvement by means of the Failure mode and effect analysis (FMEA) |
|
| | Leonor Guiñón,Anna Soler,Mónica Gisell Díaz,Rosa María Fernández,Nayra Rico,Josep Lluís Bedini,Aurea Mira,Luisa Alvarez | | | Biochemia Medica. 2020; 30(2) | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Analysis and evaluation of the external quality assessment results of quality indicators in laboratory medicine all over China from 2015 to 2018 |
|
| | Min Duan,Fengfeng Kang,Haijian Zhao,Wei Wang,Yuxuan Du,Falin He,Kun Zhong,Shuai Yuan,Bingquan Chen,Zhiguo Wang | | | Clinical Chemistry and Laboratory Medicine (CCLM). 2018; 0(0) | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Identifying risk in the use of tumor markers to improve patient safety |
|
| | Elvira Eva Moreno-Campoy,Francisco J. Mérida-De la Torre,Francisco Martos-Crespo,Mario Plebani | | | Clinical Chemistry and Laboratory Medicine (CCLM). 2016; 0(0) | | | [Pubmed] [Google Scholar] [DOI] | | | 5 |
Building a bridge to safe diagnosis in health care. The role of the clinical laboratory |
|
| | Giuseppe Lippi,Mario Plebani,Mark L. Graber | | | Clinical Chemistry and Laboratory Medicine (CCLM). 2016; 54(1): 1 | | | [Pubmed] [Google Scholar] [DOI] | |
|
